Gujarat Kidney And Super Speciality (NSE:GKSL) ROA %: 6.78% (As of Mar. 2026) — 39% Below Median


NSE:GKSL Gujarat Kidney And Super Speciality Ltd NSE:GKSL
18 GF Score
Price ₹129.23
! 5 Warning Signs
View Full Analysis

What is Gujarat Kidney And Super Speciality ROA %?

Gujarat Kidney And Super Speciality NSE:GKSL +0.83% 18 ROA % is 6.78% as of Mar. 2026, which is 39% below its 10-year median of 11.20. GuruFocus rates NSE:GKSL with a GF Score™ of 18/100. The stock has 5 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Gujarat Kidney And Super Speciality ranks better than 85.65% on this metric.

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Gujarat Kidney And Super Speciality's annualized Net Income for the quarter that ended in Mar. 2026 was ₹201.7 Mil. Gujarat Kidney And Super Speciality's average Total Assets over the quarter that ended in Mar. 2026 was ₹2,976.4 Mil. Therefore, Gujarat Kidney And Super Speciality's annualized ROA % for the quarter that ended in Mar. 2026 was 6.78%.

The historical rank and industry rank for Gujarat Kidney And Super Speciality's ROA % or its related term are showing as below:

NSE:GKSL' s ROA % Range Over the Past 10 Years
Min: 7.97   Med: 11.2   Max: 14.98
Current: 9.69

During the past 4 years, Gujarat Kidney And Super Speciality's highest ROA % was 14.98%. The lowest was 7.97%. And the median was 11.20%.

NSE:GKSL's ROA % is ranked better than
85.65% of 683 companies
in the Healthcare Providers & Services industry
Industry Median: 1.77 vs NSE:GKSL: 9.69

Gujarat Kidney And Super Speciality  (NSE:GKSL) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=201.676/2976.4
=(Net Income / Revenue)*(Revenue / Total Assets)
=(201.676 / 1223.14)*(1223.14 / 2976.4)
=Net Margin %*Asset Turnover
=16.49 %*0.4109
=6.78 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Gujarat Kidney And Super Speciality ROA % Related Terms


Gujarat Kidney And Super Speciality ROA % Historical Data

* Premium members only.

The historical data trend for Gujarat Kidney And Super Speciality's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Kidney And Super Speciality ROA % Chart

Gujarat Kidney And Super Speciality Annual Data
Trend Mar23 Mar24 Mar25 Mar26
ROA %
10.39 14.98 12.01 7.97

Gujarat Kidney And Super Speciality Quarterly Data
Mar23 Mar24 Dec24 Mar25 Jun25 Dec25 Mar26
ROA % Get a 7-Day Free Trial 15.32 5.60 32.71 11.84 6.78

NSE:GKSL vs HCA, THC, DVA: ROA % Comparison

For the Medical Care Facilities subindustry, Gujarat Kidney And Super Speciality's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gujarat Kidney And Super Speciality ROA % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Gujarat Kidney And Super Speciality's ROA % distribution charts can be found below:

* The bar in red indicates where Gujarat Kidney And Super Speciality's ROA % falls into.


NSE:GKSL
18GF Score
Gujarat Kidney And Super Speciality Ltd NSE:GKSL
ROA % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gujarat Kidney And Super Speciality ROA % Calculation

Gujarat Kidney And Super Speciality's annualized ROA % for the fiscal year that ended in Mar. 2026 is calculated as:

ROA %=Net Income (A: Mar. 2026 )/( (Total Assets (A: Mar. 2025 )+Total Assets (A: Mar. 2026 ))/ count )
=154.969/( (912.94+2976.4)/ 2 )
=154.969/1944.67
=7.97 %

Gujarat Kidney And Super Speciality's annualized ROA % for the quarter that ended in Mar. 2026 is calculated as:

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=201.676/( (0+2976.4)/ 1 )
=201.676/2976.4
=6.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2026) net income data. ROA % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROA % →
What does a ROA % of 6.78% mean?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a ROA % of 6.78% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Gujarat Kidney And Super Speciality and its competitors. This is 39% below median its historical median of 11.20. Over the past decade, Gujarat Kidney And Super Speciality's ROA % has ranged from 7.97 to 14.98. According to the industry distribution chart, Gujarat Kidney And Super Speciality ranks #98 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 14.3%.
Is Gujarat Kidney And Super Speciality's ROA % too high?
Gujarat Kidney And Super Speciality's current ROA % of 6.78% is 39% below median its 10-year median of 11.20. Over the past 10 years, this metric has ranged from a low of 7.97 to a high of 14.98. The Healthcare Providers & Services industry median ROA % is 1.77. Gujarat Kidney And Super Speciality's value of 6.78% is 283.1% above this industry median. Based on the distribution chart, Gujarat Kidney And Super Speciality ranks #98 out of 683 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Gujarat Kidney And Super Speciality has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Gujarat Kidney And Super Speciality's ROA % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gujarat Kidney And Super Speciality ranks #98 out of 683 companies for ROA %. This places Gujarat Kidney And Super Speciality in the top 14% of its industry — outperforming the majority of peers. The industry median ROA % is 1.77. Gujarat Kidney And Super Speciality's value of 6.78% is 283.1% above this benchmark. Historically, Gujarat Kidney And Super Speciality's own ROA % has ranged from 7.97 to 14.98 over the past decade. While the company's 10-year median is 11.20 vs. the industry median of 1.77, Gujarat Kidney And Super Speciality has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Healthcare Providers & Services company?
The median ROA % among Healthcare Providers & Services companies is 1.77, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gujarat Kidney And Super Speciality's current ROA % of 6.78% is 283.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Gujarat Kidney And Super Speciality and its competitors. For the Healthcare Providers & Services industry, the median ROA % is 1.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gujarat Kidney And Super Speciality's current ROA % is 6.78%, which is 39% below median its own 10-year median of 11.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Kidney And Super Speciality stock overvalued right now?
Gujarat Kidney And Super Speciality (NSE:GKSL) has a current ROA % of 6.78%. The current ROA % is 6.78%, which is 39% below median its 10-year median of 11.20 and 283.1% above the Healthcare Providers & Services industry median of 1.77. Gujarat Kidney And Super Speciality's overall GF Score™ is 18/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Gujarat Kidney And Super Speciality (NSE:GKSL), the current ROA % is 6.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gujarat Kidney And Super Speciality Business Description

Other Exchanges 544666:India
Address Jetalpur Road, Gokak Mill Compound, Plot No. 1, City Sarve No. 1537/A, Jetalpur Bridge, Anand Nagar, Haripura, Alkapuri, Vadodara, GJ, IND, 390 020
Gujarat Kidney And Super Speciality Ltd is engaged in the business of operating a chain of mid-sized multispeciality hospitals in central Gujarat and providing integrated healthcare services, with a focus on secondary and tertiary care. It offers a range of healthcare services, including General Medicine, General Surgery, Laparoscopic Surgery, Urology, Cardiology, Nephrology, and many more. The company operates in a single segment, namely Medical and Healthcare Services. It generates a substantial portion of revenue from its services to inpatients. Geographically, it operates only in India.
18GF Score

Get the complete analysis for NSE:GKSL

ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹129.23
Price